Evidence map›Paper›PMID 33285400›Full record

ArticleBreast (Edinburgh, Scotland)2021

A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland.

Laszlo Romics, Julie Doughty, Sheila Stallard, James Mansell, Vivienne Blackhall, Alison Lannigan, Suzanne Elgammal, Judith Reid, Marie-Claire McGuigan, Francesca Savioli and 6 more

Abstract read
In one paragraph

Article in Breast (Edinburgh, Scotland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. The impact of the COVID-19 pandemic on clinical staging, pathological staging and surgical management of breast cancer patients.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2024
    Article
  7. Article
  8. Breast cancer care amidst a pandemic: a scoping review to understand the impact of coronavirus disease 2019 on health services and health outcomes.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Surgical safety in the COVID-19 era: present and future considerations.Annals of surgical treatment and research · 2022
    Review
  13. Article
  14. Article
  15. Breast Reconstruction during the COVID-19 Pandemic: A Systematic Review.Plastic and reconstructive surgery. Global open · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Laszlo RomicsNew Victoria Hospital, Greater Glasgow and Clyde Health Board, NHS Scotland, United Kingdom; Academic Unit of Surgery, College of Medical, Veterinary Sciences and Life, University of Glasgow, United Kingdom. Electronic address: Laszlo.Romics@glasgow.ac.uk.
Julie DoughtyGartnavel General Hospital, Greater Glasgow and Clyde Health Board, NHS Scotland, United Kingdom.
Sheila StallardGartnavel General Hospital, Greater Glasgow and Clyde Health Board, NHS Scotland, United Kingdom.
James MansellUniversity Hospital Wishaw, Lanarkshire Health Board, NHS Scotland, United Kingdom.
Vivienne BlackhallNew Victoria Hospital, Greater Glasgow and Clyde Health Board, NHS Scotland, United Kingdom.
Alison LanniganUniversity Hospital Wishaw, Lanarkshire Health Board, NHS Scotland, United Kingdom.
Suzanne ElgammalUniversity Hospital Crosshouse, Ayrshire and Arran Health Board, NHS Scotland, United Kingdom.
Judith ReidUniversity Hospital Crosshouse, Ayrshire and Arran Health Board, NHS Scotland, United Kingdom.
Marie-Claire McGuiganNew Victoria Hospital, Greater Glasgow and Clyde Health Board, NHS Scotland, United Kingdom.
Francesca SavioliAcademic Unit of Surgery, College of Medical, Veterinary Sciences and Life, University of Glasgow, United Kingdom.
Sian ToveyUniversity Hospital Crosshouse, Ayrshire and Arran Health Board, NHS Scotland, United Kingdom.
Dermott MurphyUniversity Hospital Wishaw, Lanarkshire Health Board, NHS Scotland, United Kingdom.
Iona ReidNew Victoria Hospital, Greater Glasgow and Clyde Health Board, NHS Scotland, United Kingdom.
Andy MalyonGlasgow Royal Infirmary, Greater Glasgow and Clyde Health Board, NHS Scotland, United Kingdom.
Jennifer McIlhennyUniversity Hospital Wishaw, Lanarkshire Health Board, NHS Scotland, United Kingdom.
Christopher WilsonGartnavel General Hospital, Greater Glasgow and Clyde Health Board, NHS Scotland, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn order to minimise the risk of breast cancer patients for COVID-19 infection related morbidity and mortality prioritisation of care has utmost importance since the onset of the pandemic. However, COVID-19 related risk in patients undergoing breast cancer surgery has not been studied yet. We evaluated the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland region.

methodsA prospective cohort study of patients having breast cancer surgery was carried out in a geographical region during the first eight weeks of the hospital lockdown and outcomes were compared to the regional cancer registry data of pre-COVID-19 patients of the same units (n = 1415).

results188 operations were carried out in 179 patients. Tumour size was significantly larger in patients undergoing surgery during hospital lockdown than before (cT3-4: 16.8% vs. 7.4%; p < 0.001; pT2 - pT4: 45.5% vs. 35.6%; p = 0.002). ER negative and HER-2 positive rate was significantly higher during lockdown (ER negative: 41.3% vs. 17%, p < 0.001; HER-2 positive: 23.4% vs. 14.8%; p = 0.004). While breast conservation rate was lower during lockdown (58.6% vs. 65%; p < 0.001), level II oncoplastic conservation was significantly higher in order to reduce mastectomy rate (22.8% vs. 5.6%; p < 0.001). No immediate reconstruction was offered during lockdown. 51.2% had co-morbidity, and 7.8% developed postoperative complications in lockdown. There was no peri-operative COVID-19 infection related morbidity or mortality.

conclusionbreast cancer can be safely provided during COVID-19 pandemic in selected patients.

Indexed as

AdultAgedAged, 80 and overBreast Carcinoma In SituBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma, Intraductal, NoninfiltratingCarcinoma, LobularCohort StudiesCOVID-19Cross InfectionFemaleHumansMastectomyMastectomy, SegmentalMiddle AgedBreast cancerBreast conservation therapyBreast surgeryCOVID-19MammaplastyPandemics

Identifiers

PMID33285400
PMCPMC7687359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.